DA32 Life Science Tech Acquisition Stock (NASDAQ:DALS)


OwnershipChart

Previous Close

$10.32

52W Range

$9.68 - $11.22

50D Avg

$10.27

200D Avg

$10.09

Market Cap

$264.19M

Avg Vol (3M)

$29.06K

Beta

-

Div Yield

-

DALS Company Profile


DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Jul 28, 2021

Website

-

DALS Performance


Peer Comparison


TickerCompany
ENCPGraphjet Technology Sdn. Bhd.
DTOCAmerican Oncology Network, Inc.
LGVCLAMF Global Ventures Corp. I
GENQGenesis Unicorn Capital Corp.
ITAQIndustrial Tech Acquisitions II, Inc.
CPAAAdvantage Solutions Inc.